background preloader

Tuberculose humaine en Europe

Facebook Twitter

Tuberculose humaine en Roumanie

Tuberculose humaine en Pologne. Tuberculose humaine en Finlande. EUROSURVEILLANCE 31/1019 Tuberculosis incidence among migrants according to migrant status: a cohort study, Denmark, 1993 to 2015. Tuberculose humaine en Allemagne. EUROSURVEILLANCE 21/03/19 Tuberculosis in the European Union/European Economic Area: much progress, still many challenges. EUROSURVEILLANCE 24/01/19 Whole genome sequencing–based analysis of tuberculosis (TB) in migrants: rapid tools for cross-border surveillance and to distinguish between recent transmission in the host country and new importations. Tuberculose humaine en Italie. EUROSURVEILLANCE 05/04/18 The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic review. EUROSURVEILLANCE 22/03/18 Universal screening for latent and active tuberculosis (TB) in asylum seeking children, Bochum and Hamburg, Germany, September 2015 to November 2016.

EUROSURVEILLANCE 22/03/18 Note from the editors: World Tuberculosis Day 2018 and Special issue–Screening and prevention of infectious diseases in newly arrived migrants in Europe. EUROSURVEILLANCE 15/03/18 Find and treat or find and lose? Tuberculosis treatment outcomes among screened newly arrived asylum seekers in Germany 2002 to 2014. Screening for infectious diseases among newly arrived asylum seekers, Bavaria, Germany, 2015.

Tuberculose humaine aux Pays-Bas

BMC Public Health 06/07/17 Will the European Union reach the United Nations Millennium declaration target of a 50% reduction of tuberculosis mortality between 1990 and 2015? The Millennium Development Declaration target of 50% reduction in TB death rate was reached by the EU (28 countries) in 2014 compared to the first year with TB death data available for the EU (28 countries). Comparing the decline in TB death rates in the EU with those in other areas shows that rates are comparable.

However, the decline was more modest in the EU compared to the decline reported in the United States and Cuba. In the United States, the age-adjusted TB mortality rate declined from 2.22 per 100,000 person-years in 1990 to 0.47 per 100,000 person-years in 2006, i.e. a decline of 79% [11]. TB mortality in Cuba declined from 0.4 per 100,000 population in 1998 to 0.2 in 2007 [12]. TB mortality rates in Brazil seemed to be higher i.e. 5.9 per 100,000 in 1980 and 3.1 per 100,000 in 2001 [13].

Six EU/EEA countries did not reach the target of a 50% reduction in death rate within the period of observation, i.e. up to 2014. They reported between 144 and 15,906 TB cases in 2014 [7]. EUROSURVEILLANCE 23/03/17 Yield of active screening for tuberculosis among asylum seekers in Germany: a systematic review and meta-analysis. EUROSURVEILLANCE 23/03/17 Tuberculosis notification rate decreases faster in residents of native origin than in residents of foreign origin in the EU/EEA, 2010 to 2015.

V Hollo 1 , J Beauté 1 , C Ködmön 1 , M van der Werf 1 + Author affiliations Citation style for this article: Hollo V, Beauté J, Ködmön C, van der Werf M. Tuberculosis notification rate decreases faster in residents of native origin than in residents of foreign origin in the EU/EEA, 2010 to 2015. Euro Surveill. 2017;22(12):pii=30486. Received:22 February 2017; Accepted:16 March 2017 The tuberculosis (TB) notification rate in the European Union (EU) and European Economic Area (EEA) has been decreasing consistently since 2002 at an annual rate of around 5% [1].

Tuberculosis surveillance in the EU/EEA The surveillance of TB in Europe is carried out by the European Tuberculosis Surveillance Network under the joint coordination of the European Centre for Disease Prevention and Control (ECDC) and the WHO. Population data and analysis We obtained population denominator data by origin from the Statistical Office of the European Union (Eurostat) [5].

Trends Table Figure 1 Discussion Conclusion. EUROSURVEILLANCE 23/03/17 Ending tuberculosis in risk groups in Europe: challenges from travel and population movement. C Jackson 1 , I Abubakar 1 + Author affiliations Citation style for this article: Jackson C, Abubakar I. Ending tuberculosis in risk groups in Europe: challenges from travel and population movement.

Euro Surveill. 2017;22(12):pii=30489. DOI: Received:10 March 2017; Accepted:23 March 2017 As many countries in Europe make progress in tuberculosis (TB) control, TB incidence in Europe is diverse; in low-incidence countries (those with an incidence less than 20 per 100,000 [1]) the TB burden is increasingly borne by specific risk groups, such as migrants from high- to lower-incidence countries, persons with social risk factors such as homelessness and individuals who have been in contact with a TB patient. Arguably more controversial than screening migrants is the issue of screening individuals exposed to patients with active TB on board aircraft. PARLEMENT EUROPEEN - Réponse à question E-010041-15 European strategy for tackling tuberculosis. PARLEMENT EUROPEEN - Réponse à question E-009764-15 Tuberculosis in the EU. PARLEMENT EUROPEEN - Réponse à question E-005319-15 Campaign against tuberculosis in Europe and worldwide.

Tuberculose humaine en France

Références ECDC. Références Eurosurveillance. Tuberculose humaine en Espagne. Tuberculose humaine au Royaume-Uni. En Irlande. En Belgique. EUROPE 31/05/07 Tuberculose ultra-résistante: après le passage en Europe d’un voyageur infecté, les États membres de l’Union ado. IRB BARCELONA 07/10/09 IRB Barcelona to participate in a European project against tuberculosis. IRB Barcelona to participate in a European project against tuberculosis Tuberculosis is one of the major health threats worldwide. Every year more than 2 million people die from this infectious disease, which is caused by Mycobacterium tuberculosis. The lack of effectiveness of drug treatments because of the appearance of strains that show multi-resistance to new drugs has made tuberculosis a focus of international research to define new therapeutic tools against this disease. 7 October 2009 The project NOstress (Unravelling the molecular mechanism of nitrosative stress resistance in tuberculosis), included in the health section of the 7th Framework Programme of the European Union and coordinated at international level by professor Javier Luque at the Dept.

Of Physical Chemistry at the University of Barcelona, seeks to design new treatments to combat tuberculosis, a disease with a particularly high incidence in Asia and Africa. EFSA DEC 2007 Rapport annuel de l’EFSA-ECDC sur les infections transmissibles de l’animal à l’homme. Communiqué de presse 19 décembre 2007 L’Autorité européenne de sécurité des aliments (EFSA) et le Centre européen de prévention et de contrôle des maladies (ECDC) ont publié leur rapport annuel communautaire conjoint sur les maladies infectieuses transmissibles de l’animal à l’homme (maladies zoonotiques) qui, chaque année, touchent plus de 350 000 personnes dans l’Union européenne.

Ce rapport indique que, tandis que le nombre d’infections à Salmonella chez l’homme est toujours en baisse, les infections à Listeria, qui peuvent s’avérer très dangereuses chez les femmes enceintes et entraînent un taux de mortalité élevé, connaissent une recrudescence. Les infections à Campylobacter figurent encore en tête de liste des zoonoses signalées chez l’homme. La résistance de la bactérie Campylobacter tant chez l’homme que chez l’animal à un médicament antimicrobien couramment utilisé, la ciprofloxacine, atteint des niveaux élevés et devient inquiétante selon ce rapport. EFSA 28/01/10 L’EFSA et l’ECDC présentent leur rapport sur les zoonoses et les épidémies d’origine alimentaire dans l’Union euro. EFSA Journal; 2010 8(1):1496 [410 pp.]. doi:10.2903/j.efsa.2010.1496 Type: Scientific Report of EFSA Question number: EFSA-Q-2009-00695 Approved: 23 December 2009 Published: 28 January 2010 Last updated: 30 July 2010.

This version replaces the previous one/s. Affiliation: European Food Safety Authority (EFSA), Parma, Italy This scientific output, published 26 April 2010, replaces the earlier version published on 28 January 2010. Zoonoses are infections and diseases that are naturally transmissible directly or indirectly, for example via contaminated foodstuffs, between animals and humans. In 2008, 27 Member States submitted information on the occurrence of zoonoses, zoonotic agents and food-borne outbreaks to the European Commission and the European Food Safety Authority.

In 2008, salmonellosis was again the second most often reported zoonotic disease in humans accounting for 131,468 confirmed human cases. An important decline in the prevalence of S. INVS 23/03/04 La surveillance de l'épidémie de tuberculose en Europe menacée par l'interruption du financement de la Commission.